4th Annual Pharma Forecasting Excellence 2010

October 5-6 2010 | Boston, MA

As big pharma refocuses its strategy for the next decade, how will this impact your forecasting process? save your place today

eyeforpharma invites you to learn how to optimize forecasts and drive your portfolio strategy into the new decade at our Pharma Forecasting Excellence USA Summit.

This year’s summit is set to exceed all expectations with a fantastic new speaker line-up. Hot topics to be addressed include:

• Emerging Markets, emerge victorious - execute the winning strategy when assessing market potential and accessibility of new territories
• A change of tactics... as small patient segments become new targets, what does this mean for your forecasting process?
• Develop an S&OP strategy which goes beyond the basics and translates into a meaningful strategy across the business
• Get in-sync with R&D: Bridge the gap between clinical development forecasts and evaluate early stage products effectively

Check out the full program by clicking here: Pharma Forecasting 2010 Brochure

Benefit from thought-leaders in the industry who will deliver interactive workshops, keynote presentations and practical case studies on these very topics, including:

• Peter Sandor, VP & Commercial Head, Bayer
• Robert Livesay, AVP New Products Marketing -
  Head, Phase III, sanofi-aventis
• Bob Draper, Head of Global Forecasting, Eli Lilly
• Marie Lamont, VP Finance & Operations, Genzyme
• Reid Graves, Business Process Senior Lead, SCM Master Data, Merck
• Michael Devinoff, Executive Director, Forecasting, Epidemiology & Predictive Analytics Bristol-Myers Squibb

Early registrants benefit from bigger discounts – click here to
save your place today, or contact Camilla Ohlsson on cohlsson@eyeforpharma.com or +44 207 375 7223.